These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 13535357)

  • 1. [Pharmacological properties of 1,2-diphenyl-4-(gamma-ketobutyl)-pyrazolidine-3,5-dione].
    HORAKOVA Z; NEMECEK O; PUJMAN V; MAYER J; CTVRTNIK J; VOTAVA Z
    Arzneimittelforschung; 1958 Apr; 8(4):229-31. PubMed ID: 13535357
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological studies of 2-diphenyl-r4-(gamma-ketobutyl)-pyrazolidine-3, 5-dione].
    Kameyama T; Oyanagi K; Magao S; Yamada T
    Nihon Yakurigaku Zasshi; 1968 Mar; 64(2):1-9. PubMed ID: 5749290
    [No Abstract]   [Full Text] [Related]  

  • 3. [About the glucoside of 1,2-diphenyl-3,5-dioxo-4-n-butyl-pyrazolidine (phenylbutazone)].
    MOREL CJ
    Experientia; 1958 Aug; 14(8):294-5. PubMed ID: 13574145
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of 3,5-dioxo-1,2-diphenyl-4-n-butyl pyrazolidine and 3,5-dioxo-1-phenyl-2-p-hydroxyphenyl-4-butyl pyrazolidine on the incorporation of C14-leucine into the blood plasma proteins of the isolated rat liver].
    JUNGBLUT PW
    Arzneimittelforschung; 1959 Sep; 9():549-51. PubMed ID: 14408193
    [No Abstract]   [Full Text] [Related]  

  • 5. [Synthesis and pharmacological properties of 1-phenyl-2-(4'-hydroxy-3'-carboxymethyl)-phenyl-4-n-butyl-3, 5-dicheto-pyrazolidine and of 1-p-nitrophenol-4-n-butyl-3, 5-dicheto-pyrazolidine].
    BERGESI G; SANTI SONCIN E; STUCCHI F
    Rass Clin Ter; 1961; 60():177-87. PubMed ID: 13867703
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolites of feprazone in man.
    Yamaguchi H; Kubo J; Sekine K; Naruchi T; Hashimoto Y; Kato R
    Drug Metab Dispos; 1979; 7(5):340-4. PubMed ID: 40778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Some derivatives of 1,2-diphenyl-4-butyl-3, 5-pirazolidine-dione. II].
    FRANCHI G
    Farmaco Sci; 1956; 11(10):819-22. PubMed ID: 13414852
    [No Abstract]   [Full Text] [Related]  

  • 8. [Differentiation of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine (phenylbutazone) and 3,5-dioxo-1,2-diphenyl-4-prenyl-pyrazolidine (prenazone) using reaction chromatography].
    schütz C; Schütz H
    Arzneimittelforschung; 1973 Mar; 23(3):428-31. PubMed ID: 4740130
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acid-base equilibrium in connective tissue and dependent changes under the influence of 1, 2-diphenyl-4-butyl-3, 5-pyrazolidine-dione. 1. Theoretical basis].
    von SCHWEINITZ H; LINDNER J; ECKSTEIN M
    Arzneimittelforschung; 1960 Nov; 10():899-901. PubMed ID: 13749227
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of the pharmacological properties of various salts of phenylbutazone and the effects of its simultaneous administration with 1-ascorbic acid].
    WILHELMI G
    Farmaco Sci; 1958; 13(12):922-33. PubMed ID: 13619732
    [No Abstract]   [Full Text] [Related]  

  • 11. [Original pyrazolidine preparations of the Czechoslovak industry (Ketazone Spofa and Benetazone Spofa); findings obtained through the study of blood levels in man].
    Cepelák V; Mayer O; Cepeláková H
    Cesk Farm; 1977 Jul; 26(6):247-54. PubMed ID: 578785
    [No Abstract]   [Full Text] [Related]  

  • 12. [The mechanism of action of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine; complex forming ability of this compound and effects on diphosphopyridine nucleotide-dependent zinc enzymes].
    WALLENFELS K; SUND H
    Arzneimittelforschung; 1959 Feb; 9(2):81-9. PubMed ID: 13638188
    [No Abstract]   [Full Text] [Related]  

  • 13. [Protein binding of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine and several other drugs].
    WUNDERLY C
    Arzneimittelforschung; 1956 Dec; 6(12):731-4. PubMed ID: 13395938
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacological properties of the metabolites of 1,2-diphenyl-3,5-dioxo-4-n-butylpyrazolidine].
    WILHELMI G
    Arzneimittelforschung; 1960 Feb; 10():129-33. PubMed ID: 13855379
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiments on the effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine. I. Distribution in organism after a single intravenous injection].
    HEISE ER; KIMBEL KH
    Arzneimittelforschung; 1956 Dec; 6(12):722-4. PubMed ID: 13395933
    [No Abstract]   [Full Text] [Related]  

  • 16. ["Comparative study of several drugs belonging to the group of the 1,2-diphenyl-3,5-diketopyrazolidines. I."].
    PICCININI F; MARAZZI-UBERTI E; LUGARESI C
    Arch Int Pharmacodyn Ther; 1961 Jun; 132():16-28. PubMed ID: 13735416
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiments on the effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine in rats. II. Distribution of the drug in the organism after repeated oral doses].
    HEISE ER
    Arzneimittelforschung; 1956 Dec; 6(12):724-6. PubMed ID: 13395934
    [No Abstract]   [Full Text] [Related]  

  • 18. [Penetration of human aqueous humor by 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine (butazolidin)].
    MUNICH W
    Albrecht Von Graefes Arch Ophthalmol; 1958; 160(2):181-5. PubMed ID: 13545132
    [No Abstract]   [Full Text] [Related]  

  • 19. [Toxicity and kinetics of the elimination of 4-butyl-2-phenyl-3, 5-pyrazolidinedione compared with that of the 1,2-diphenyl derivative].
    SCARSELLI V
    Farmaco Sci; 1959; 14(5):347-51. PubMed ID: 13663921
    [No Abstract]   [Full Text] [Related]  

  • 20. [On an iodinated derivative of 1,2-diphenyl-4-n-butyl-3,5-pyrazolidinedione].
    CONTI L
    Farmaco Prat; 1961 May; 16():240-3. PubMed ID: 13695183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.